Deka Bank Deutsche Girozentrale Abbott Laboratories Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Abbott Laboratories stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 2,543,279 shares of ABT stock, worth $291 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

2,543,279

Previous 2,624,017 3.08%

Holding current value

$291 Million

Previous $276 Million 3.22%

% of portfolio

0.53%

Previous 0.5%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $8.08 Million - $9.54 Million	-80,738 Reduced 3.08%	2,543,279 $285 Million
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $3.6 Million - $4.02 Million	-35,714 Reduced 1.34%	2,624,017 $276 Million
Q1 2024 Apr 24, 2024	SELL	$109.52 - $120.96 $7.09 Million - $7.83 Million	-64,728 Reduced 2.38%	2,659,731 $303 Million
Q4 2023 Jan 24, 2024	SELL	$90.19 - $110.4 $516,878 - $632,702	-5,731 Reduced 0.21%	2,724,459 $300 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $1.89 Million - $2.26 Million	-19,746 Reduced 0.72%	2,730,190 $268 Million
Q2 2023 Jul 25, 2023	BUY	$100.78 - $112.29 $75.7 Million - $84.4 Million	751,589 Added 37.61%	2,749,936 $297 Million
Q1 2023 Apr 24, 2023	BUY	$96.86 - $114.01 $4.32 Million - $5.08 Million	44,579 Added 2.28%	1,998,347 $197 Million
Q4 2022 Feb 01, 2023	BUY	$95.06 - $111.52 $10.1 Million - $11.9 Million	106,578 Added 5.77%	1,953,768 $214 Million
Q3 2022 Nov 02, 2022	SELL	$96.76 - $112.03 $660,387 - $764,604	-6,825 Reduced 0.37%	1,847,190 $180 Million
Q2 2022 Aug 03, 2022	BUY	$102.07 - $123.37 $1.23 Million - $1.49 Million	12,055 Added 0.65%	1,854,015 $200 Million
Q1 2022 Apr 28, 2022	SELL	$114.02 - $139.04 $1.93 Million - $2.35 Million	-16,892 Reduced 0.91%	1,841,960 $222 Million
Q4 2021 Feb 02, 2022	SELL	$115.53 - $141.46 $3.63 Million - $4.44 Million	-31,386 Reduced 1.66%	1,858,852 $265 Million
Q3 2021 Oct 22, 2021	SELL	$116.66 - $129.06 $51.2 Million - $56.7 Million	-439,197 Reduced 18.85%	1,890,238 $227 Million
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $71.8 Million - $84.5 Million	-678,786 Reduced 22.56%	2,329,435 $272 Million
Q1 2021 Apr 28, 2021	BUY	$108.84 - $128.23 $6.43 Million - $7.57 Million	59,049 Added 2.0%	3,008,221 $362 Million
Q4 2020 Mar 12, 2021	BUY	$105.0 - $114.42 $112 Million - $122 Million	1,067,460 Added 56.73%	2,949,172 $322 Million
Q3 2020 Oct 29, 2020	BUY	$91.64 - $111.29 $46.4 Million - $56.4 Million	506,668 Added 36.85%	1,881,712 $199 Million
Q2 2020 Aug 04, 2020	BUY	$76.57 - $98.0 $6.99 Million - $8.95 Million	91,302 Added 7.11%	1,375,044 $122 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $3.49 Million - $5.1 Million	55,542 Added 4.52%	1,283,742 $104 Million
Q4 2019 Feb 04, 2020	SELL	$78.51 - $87.4 $18.1 Million - $20.1 Million	-230,345 Reduced 15.79%	1,228,200 $108 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $352,403 - $382,114	4,306 Added 0.3%	1,458,545 $120 Million
Q2 2019 Aug 01, 2019	BUY	$72.88 - $85.0 $50.6 Million - $59 Million	694,262 Added 91.35%	1,454,239 $122 Million
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $3.16 Million - $3.82 Million	-47,672 Reduced 5.9%	759,977 $51.4 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $3.13 Million - $3.54 Million	47,672 Added 6.27%	807,649 $57.5 Million
Q3 2018 Nov 09, 2018	BUY	$60.81 - $73.36 $2.37 Million - $2.86 Million	38,935 Added 5.4%	759,977 $0
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $707,247 - $780,588	-12,285 Reduced 1.68%	721,042 $44.5 Million
Q1 2018 May 03, 2018	SELL	$56.27 - $63.62 $1.27 Million - $1.43 Million	-22,526 Reduced 2.98%	733,327 $44 Million
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $36.3 Million - $40.5 Million	755,853	755,853 $38 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Abbott Laboratories Transaction History